Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Life Sciences Companies To Steer Patents Away From New European Court

This article was originally published in Scrip

Executive Summary

All healthcare and life sciences companies that responded to a survey by the law firm Hogan Lovells will opt their most important patents out of the European Unified Patent Court. The findings signal cautious joined up thinking on how companies will approach the new court, which is scheduled to launch in 2017.

Advertisement
Advertisement
UsernamePublicRestriction

Register